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Purpose: This research was conducted to make a primary culture of human retinal capillary endothelial cells (HRCEC)
and to study the cytotoxic effect of human immunodeficiency virus-1 (envelope) glycoprotein 120 (HIV-1 gp120) on
cultured HRCEC.
Methods: HRCEC were isolated and primarily cultured as dissociated single cell cultures. Immunohistochemistry and
immunofluorescence were used to identify specific markers of HRCEC and to reveal HIV-1 gp120 related receptors
(cluster of differentiation 4 [CD4], C-X-C chemokine receptor type 4 [CXCR4], and C-C chemokine receptor type 5
[CCR5]). The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay was used to demonstrate the
effect of HIV-1 gp120 on cell viability at seven different concentrations (0.01–0.15 mg/l) for 24 h or at a fixed concentration
of 0.08 mg/l for varying time intervals (4–72 h). After 0.08, 0.1, 0.12, and 0.15 mg/l HIV-1 gp120 were applied to HRCEC
for 24 h, cell apoptotic rates and the mitochondrial membrane potential were measured with flow cytometry; pro-caspase-9
and cleaved caspase-9 were evaluated with immunoblotting. Under each research condition, 0.15 mg/l of HIV-1 gp120
mutated proteins (423 I/P) were used as controls.
Results: Primary cultures of pure HRCEC were established, and the cells were characterized with their specific markers.
HIV-1 gp120 receptors CXCR4 and CCR5 were found on the cell surface of HRCEC; however, CD4 was negative.
Treatment of HRCEC with HIV-1 gp120 at concentrations <0.08 mg/l did not influence cell viability. However, a
concentration- and time-dependent increase of HIV-1 gp120-induced cell inhibition was demonstrated with MTT, when
the concentration of HIV-1 gp120 was more than 0.08 mg/l (r=-0.763, p<0.01). With increasing concentrations of HIV-1
gp120, the numbers of apoptotic cells and expression of cleaved caspase-9 protein increased, but Rho123 staining
mitochondrial membrane potential decreased.
Conclusions: HIV-1 gp120 assistant receptors CXCR4 and CCR5 are expressed on the cell surface of HRCEC, and HIV-1
gp120 can inhibit cell viability and induce apoptosis of HRCEC. The mitochondrial pathway is probably involved in
HIV-1 gp120-induced apoptosis of HRCEC, but the specific mechanisms remain to be uncovered.
Along  with  the  increasing  numbers  of  patients  with
human  immunodeficiency  virus  type  1  (HIV-1),  HIV-1-
related  eye  diseases  have  become  a  great  challenge  for
ophthalmologists all over the world. Severe retinopathy and
uveitis [1] are the main untreatable causes of ablepsia in these
patients, since the pathogenesis has remained unclear until
now. However, researchers have believed that disruption of
the structure and function of the blood-retina barrier (BRB) is
the primary cause [2-5]. The BRB consists of the outer barrier
(retina pigment epithelial cells and their tight junctions) and
the inner barrier (retina capillary endothelial cells and their
tight junctions), both of which are important in maintaining
the integrity and normal function of the BRB. Our previous
research focused on the destruction of the outer barrier by
HIV-1 proteins [6,7], but further research about the inner
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barrier  was  delayed  until  we  could  successfully  establish
primary  cultures  of  inner  blood-retina  barrier  cells  [8].
Whether the destruction of the inner barrier is more important
than that of the outer barrier to HIV-1 retinopathy has not been
proved.
It is well known that HIV-1 infections involve binding of
the  viral  external  envelope  glycoprotein  (gp120)  to  cell-
surface cluster of differentiation 4 (CD4) molecules, followed
by  interactions  with  coreceptors  of  C-X-C  chemokine
receptor type 4 (CXCR4) and C-C chemokine receptor type 5
(CCR5; T cells and macrophage cell-surface binding of the
natural chemokine receptors), which results in the fusion of
the viral and cellular membranes [9]. In addition, previous
studies demonstrated that dissociated HIV-1 gp120 in blood
is toxic to cells through the HIV-1 related coreceptor (CXCR4
and  CCR5),  inducing  oxidative  stress,  inflammatory
cytokines, apoptosis, and tight junction injury [10,11]. Our
previous  studies  revealed  that  HIV-1  gp120  could  induce
oxidative stress in human retina pigment epithelial cells [6],
but the influence of HIV-1 gp120 on human retinal capillary
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3450endothelial  cells  (HRCEC)  and  its  mechanism  remained
unknown. To clarify this question in the current research, we
first established primary cultures of HRCEC identified by
specific  markers  (von  Willebrand  factor  and  zonula
occludens-1).  At  the  same  time,  the  expression  of  HIV-1
related receptors (CD4, CXCR4, and CCR5) was investigated,
and further we exposed primary cultured HRCEC to HIV-1
gp120. Thereafter, the cytotoxic effect of HIV-1 gp120 on
cultured HRCEC was investigated to explore the possible
molecular mechanism.
METHODS
Reagents: Gp120, obtained from the National Institutes of
Health  AIDS  Reagent  Program  (Rockville,  MD),  was  a
generous  gift  from  Prof.  Hui  Zhang  of  Thomas  Jefferson
University (Philadelphia, PA). Dulbecco’s modified Eagle’s
medium/High Glucose (DMEM), fetal bovine serum (FBS),
penicillin, and streptomycin were purchased from Hyclone
(Logan,  UT).  Rat  antihuman  CD4,  CXCR4,  and  CCR5
monoclonal antibodies were purchased from R&D Systems
(Shanghai,  China).  Rabbit  antibodies  against  (cleaved)
caspase-9  antibody  (No.  9501-Asp330,  No.  9502)  were
obtained from Cell Signaling Technology (Danvers, MA).
Except for those indicated in the text, all other chemicals and
reagents were obtained from Invitrogen/Gibco (Grand Island,
NY).
Tissue source, primary culture, and identification of HRCEC:
This  study  was  performed  in  accordance  with  the  ethical
standards laid down in the 1964 Declaration of Helsinki for
Research Involving Human Tissue. After receiving consent
for research use and Sun Yat-sen University ethics committee
approval,  six  postmortem  eyes  (donors  age  24–32)  were
obtained from the Eye Bank of Zhongshan Ophthalmic Center
(Guangzhou, China) 8–24 h after death. Only eyes free of
ocular pathology were used to establish primary cultures. The
research  was  conducted  according  to  the  tenets  of  the
Declaration of Helsinki.
The  methods  for  isolating,  culture,  and  identifying
HRCEC were described in our recent published paper [8],
which was focusing on primary culture of human retina cells.
To investigate HIV-1 related receptors (CD4, CXCR4, and
CCR5) in HRCEC, antibodies against CD4, CXCR4, and
CCR5  were  used  and  analyzed  with  immunofluorescent
staining and immunocytochemistry microscopy.
Preparation and treatment of gp120 protein: A solution of
gp120 with a concentration of 2 g/l was made by adding
100 µg freeze-dried powder of gp120 in 50 µl PBS. Then the
prepared solution was stored at −20 °C, and was diluted with
serum-free culture fluid when used. HRCEC were cultured in
the plastic plates (Sigma, St. Louis, MO) until subconfluence
and treated with gp120 at concentrations [12] of 0.01, 0.02,
0.04, 0.08, 0.1, 0.12, and 0.15 mg/l for 24 h, or with 0.08 mg/
l of HIV-1 gp120 solution culture for different periods of 4,
8, 12, 24, 48, and 72 h. In the control group, HRCEC were
treated with 0.15 mg/l of HIV-1 gp120 mutated proteins (423
I/P), which did not bind to CD4 or CXCR4/CCR5 as a result
of the disruption of the HIV-1 gp120 bridging sheet [13], and
the other conditions were the same as each research group.
Each experiment was repeated at least three times.
Cell viability assay: Cells were grown in 96-well plates at a
density of 1×104 cells/well. After the indicated treatments, 3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide
(MTT) was added to a final concentration of 5 g/l to each well
for 4 h, after which the culture medium was removed and
150 μl of dimethyl sulfoxide (DMSO) was added to each well.
Absorbance at 490 nm was measured using a multifunctional
microplate  reader  (POLARstar  OPTIMA,  BMG
Labtechnologies, Ortenberg, Germany).
Evaluation of apoptosis: Apoptotic rates were analyzed with
flow  cytometry  (FACS)  using  the  Annexin  V-fluorescein
isothiocyanate (FITC)/propidium iodide (PI) kit (Sigma, St.
Louis,  MO),  in  which  annexin  V  binds  to  the  exposed
phosphatidylserine  on  the  plasma  membrane  of  apoptotic
cells. Staining was performed according to the manufacturer’s
instructions provided by Sigma Company (Sigma), and FACS
was  conducted  on  a  FACS  Caliber  (Becton  Dickinson,
Mountain View, CA). The percentage of the early apoptosis
was calculated from the proportion of cells that was annexin
V-positive but PI-negative, while the percentage of the late
apoptosis plus necrosis was calculated from the proportion of
cells that was annexin V- and PI-positive.
Measurement of mitochondrial membrane potential: Loss of
the mitochondrial membrane potential (ΔΨm) was assessed
with  flow  cytometry  using  the  fluorescent  indicator
Rhodamine123  (Rho123;  Sigma),  as  previously  described
[14].  Briefly,  Rho123  working  solution  was  added  to  the
culture to a final concentration of 2 g/l, and then the culture
was incubated in the dark for 30 min at 37 °C. Cells were then
washed with PBS and evaluated immediately for Rho123
fluorescence  using  a  FACS  Caliber,  at  an  excitation
wavelength of 488 nm and an emission wavelength of 525 nm.
Western blot analysis: Cells were lysed with 20 ml of ice-cold
lysis buffer (50 mM HEPES, 5 mM EDTA [EDTA], 100 mM
NaCl, 1% Triton X-100 pH 4) in the presence of a protease
inhibitor  cocktail  (Roche,  Berlin,  Germany).  Protein
concentrations were determined with the bicinchoninic acid
(BCA)  protein  assay  kit  (Pierce,  Rockford,  IL).  Protein
samples (20 μg) were resolved on 10% sodium dodecyl sulfate
PAGE  (SDS–PAGE)  gels  and  transferred  onto  a
polyvinylidene  difluoride  (PVDF)  membrane  (Millipore,
Bedford, MA) using a semi-dry system (Bio-Rad, Hercules,
CA). The membranes were incubated with specific antibodies
against pro-caspase-9 (No. 9502), cleaved caspase-9 (Asp330
No. 9501; 1:100) and β-actin (1:500). β-actin was used as a
loading  control  in  experiments  with  cellular  proteins.
Chemiluminescence  was  visualized  by  exposure  to  X-ray
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3451Figure 1. Expression of CD4, CXCR4, and CCR5 in HRCEC. CXCR4 (C and D) and CCR5 (E and F) receptors were positive on the cell
surface of HRCEC, but the CD4 receptor (A and B) was negative. A, C, and E were by immunocytochemistry; B, D, and F were by
immunofluorescent staining. To focus on specific markers in immunofluorescent staining, 4', 6-diamidino-2-phenylindole (DAPI) nuclear
staining on B, D, and F was not displayed. Three independent experiments were performed.
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3452films. The optical densities of the bands were scanned and
quantified  with  Gel  Doc  2000  (Bio-Rad).  Data  were
normalized to those of the corresponding β-actin levels.
Statistical  analysis:  Data  are  expressed  as  the  mean±SD.
Differences  between  groups  were  assessed  with  one-way
ANOVA,  and  the  correlation  of  bivariate  between  the
concentration of gp120 and its cytotoxic effect were analyzed
with  a  statistical  software  program  (SPSS  17.0;  SPSS,
Chicago, IL). p<0.05 was considered indicative of statistical
significance.
RESULTS
Primary culture and identification of HRCEC: HRCEC were
cultured, maintained, and passaged using specially designed
media and following the procedures optimized by our research
group as described previously [8]. The purity of HRCEC was
analyzed  with  immunochemistry  staining  and
immunofluorescence microscopy and confirmed with FACS
with antibodies against its specific markers. As indicated in
our previous research [8], primary HRCEC expressed von
Willebrand factor and zonula occludens-1.
Investigation of HIV-1 gp120 related receptors in HRCEC:
According  to  the  immunocytochemistry  and
immunofluorescence,  CXCR4  and  CCR5  receptors  were
found on the cell surface of HRCEC, while the CD4 receptor
was not. Data are shown in Figure 1.
Effect  of  HIV-1  gp120  on  cell  viability  of  HRCEC:  To
determine the cytotoxicity of HIV-1 gp120 on HRCEC, we
used  the  concentration  gradient  of  gp120  and  various
exposure durations to demonstrate the cytotoxicity with MTT
assay. In groups treated with low concentrations (<0.08 mg/
l) of gp120 protein, HIV-1 gp120 protein demonstrated no
significant effect on the viability of HRCEC. However, in
groups  with  a  concentration  of  gp120  protein  exceeding
0.08 mg/L, the HIV-1 gp120 protein appeared to significantly
inhibit the cell viability of HRCEC in 24 h, showing a clear
dose-dependent manner in Figure 2A (r=-0.763, p<0.001). In
groups treated with a fixed concentration of 0.08 mg/l, HIV-1
Figure 2. Effects of HIV-1 gp120 on the
cell  viability  of  HRCEC.  A:  Dose–
response effects of HIV-1 gp120 for 24
h in an MTT assay. B: Time course of
the effects of HIV-1 gp120 on HRCEC.
HRCEC were incubated with 0.08 mg/l
of HIV-1 gp120 for the times indicated.
Cellular  viability=(absorbance  rate  of
study group÷absorbance rate of control
group)  ×100%.*p<0.05,  #  p<0.01
compared with control (HIV-1 gp120
mutated proteins, 423 I/P). Each data
point represents the mean±SD of three
independent experiments.
Figure  3.  Apoptotic  cell  death  of
HRCEC  treated  with  HIV-1  gp120.
After  being  treated  with  gp120  at
concentrations of 0.08, 0.1, 0.12, and
0.15 mg/l for 24 h, apoptotic cells were
analyzed using the annexin V-FITC/PI
double marked method by FCM. Early
apoptotic cells were annexin -positive
but PI-negative (left blank plots); late
apoptotic ells were annexin V- and PI-
positive  (right  corrugated  plots).  The
ratio  of  apoptotic  cells  increased
significantly with the increase of protein
concentration. #p<0.01 compared with
control. Data represent the mean±SD of
three independent experiments.
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3453gp120 could significantly inhibit the viability of HRCEC after
12  h  culture,  showing  a  time  dependence  in  Figure  2B
(r=-0.833, p<0.001).
Induction of apoptosis in HRCEC by HIV-1 gp120: To clarify
the mechanism of gp120-induced cytotoxicity on HRCEC, we
examined early and late apoptosis in HRCEC using annexin
V-FITC and PI double labeling of living cells. Annexin V
Figure  4.  Collapse  of  mitochondrial
membrane  potential  (ΔΨm)  measured
with  FCM  in  HRCEC  treated  with
HIV-1 gp120. The fluorescence signal
of Rho123 decreased significantly with
the  increase  of  the  HIV-1  gp120
concentration.  *p<0.05,  #  p<0.01
compared with control. Data represent
the  mean±SD  of  three  independent
experiments.
Figure  5.  Expression  of  caspase-9  in
HRCEC with or without HIV-1 gp120
treatment. A: western blot showed the
expression of pro-caspase-9 (full length,
using antibody No. 9502) and cleaved
caspase-9 (37 kDa, using antibody No.
9501-Asp330)  in  HRCEC  without  or
with gp120 treatment. The activation of
caspase-9 is reflected by the appearance
of the bands representing the 37-kDa
cleavage product. B: The densities of the
bands were quantified with Bio-Rad Gel
Doc  2000.  Arbitrary  densitometry  of
cleaved  caspase-9  show  that  its
expression increases significantly with
the  increase  of  HIV-1  gp120  protein
concentration. #p<0.01 compared with
control. Data represent the mean±SD of
three independent experiments.
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3454binds to phosphatidylserine exposed on the cell membrane,
one of the earliest indicators of cellular apoptosis. As shown
in the plots in Figure 3,  FACS analysis revealed that the
numbers of early and late apoptotic cells increased with gp120
exposure  in  a  dose-dependent  manner.  When  the
concentration of gp120 was >0.08 mg/l, the difference was
significant compared with control.
Involvement of the mitochondrial pathway in HIV-1 gp120-
induced  apoptosis:  Mitochondria  play  a  crucial  role  in
regulating cell death, and the loss of ΔΨm is an irreversible
event in the mitochondrial apoptotic pathway. To confirm
whether  gp120  causes  the  loss  of  ΔΨm  in  HRCEC,  we
evaluated  Rho123  fluorescence  in  the  cells,  while  the
depolarization of ΔΨm was assessed by the reduced Rho123
accumulation  in  the  mitochondria.  We  employed  this
indicator to estimate the effect of gp120 on the ΔΨm. As
shown in Figure 4, treatment of cells for 24 h with 0.08, 0.1,
0.12, and 0.15 mg/l of gp120 led to significantly decreasing
Rho123 fluorescence in a dose-dependent manner (r=-0.842,
p<0.001).
However, caspase-9 activation also occurs mainly via the
mitochondrial pathway, so we tested the effect of gp120 on
the activation of caspase-9 at the same time. As shown in
Figure 5, treatment with gp120 caused significantly increasing
cleavage  of  pro-caspase-9  in  a  dose-dependent  manner
(r=0.792, p<0.001). These two results together indicate that
HIV-1 gp120 induces apoptosis of HRCEC most likely via the
mitochondrial  pathway,  though  the  specific  mechanism
remains to be studied.
DISCUSSION
HIV-1-associated retinopathy (disruption of the blood-retina
barrier) is a great threat to human visual function and quality
of life [15]. The most likely effect of blood-retina barrier
disruption on infections is increased access to ocular tissues
and perhaps increased access of immune cells to the eye [3,
16].  However,  the  specific  mechanisms  of  the  impact  of
HIV-1 on the human blood-retinal barrier are not yet known
[17].
Gp120,  a  highly  glycosylated  hydrophilic  envelope
protein of HIV-1, located on the virus particles and infected
cell surface, or just in free form, has the ability to target the
cell surface of CD4 and CXCR4/CCR5 receptors [18-20].
Gp120 involves many types of cells and may cause injury and
even  apoptosis  of  different  cells,  even  without  the  CD4
receptor  [21].  Ullrich  et  al.  [22]  reported  that  binding  of
gp120/160  with  CXCR4  induces  caspase-dependent
apoptosis of human umbilical endothelial cells, which are not
CD4+ cells but uninfected CXCR4-positive bystander cells.
Researchers have also demonstrated that the viral envelope
glycoprotein gp120 plays a key role in the process of HIV-1
violation of blood-brain barrier [23-25]. In our study, we
found that the CD4 receptor was not expressed on HRCEC,
but CXCR4/CCR5 receptors were indeed expressed on the
cell surface of HRCEC. Although the source of the cells in
Ullrich’s  study  (human  umbilical  endothelial  cells)  was
different from that in our study [22], our results (HRCEC,
newly proved uninfected CXCR4/CCR5-positive bystander
cells)  confirm  Ullrich’s  finding,  and  suggest  the  gp120-
induced damage to HRCEC is also probable mediated by the
CXCR4/CCR5 receptor.
To appropriately demonstrate the toxic effects of HIV-1
gp120  protein  on  HRCEC,  we  have  to  find  a  suitable
concentration. From the present studies about gp120 cellular
toxicity, the concentration range varied widely, from 1 pM to
10  uM  (0.12  ng/ml–120  mg/l  range,  1  nM=0.12  mg/l).
However, the clinical studies reported by Oh et al. [26] that
the concentration of gp120 in plasma of patients with acquired
immune  deficiency  syndrome  was  0.1–0.8  nM  (0.012–
0.096 mg/l). Therefore, we chose to use the concentration of
gp120  from  0.01  to  0.15  mg/l,  which  covered  the
concentration range in the actual situation of patients with
acquired  immune  deficiency  syndrome.  When  the  protein
levels  are  >0.08  mg/l,  HIV-1  gp120  induced  significant
inhibition of the cell viability of HRCEC in a dose- and time-
dependent manner. With the increasing concentration, the rate
of  HRCEC  apoptosis  statistically  significantly  increased
compared to the control group.
As we know, mitochondria are the core of the intrinsic
apoptosis pathway, storing many cysteinyl aspartate specific
proteinase–induced  activation  and  chromosome  breakage
proteins  [27,28].  The  role  of  mitochondria  in  apoptosis
includes  the  release  of  caspase-activating  factors  such  as
cytochrome  C,  the  loss  of  electron  transfer  function  and
reduction in energy generation, the disappearance of ΔΨm as
well as the related function of the Bcl-2 family of proteins to
promote  and  inhibit  apoptosis.  The  mitochondrial
participation in apoptosis is connected with the collapse of the
ΔΨm, which is considered the “point of no return” in the death
cascade [29]. Our results demonstrated that HIV-1 gp120
enhanced  the  collapse  of  ΔΨm  and  caspase-9  activation,
which may lead to a significant increase in mitochondrial
breakdown.  In  all,  these  results  indicated  that  the
mitochondrial pathway is probably involved in HIV-1 gp120-
induced apoptosis of HRCEC, but the specific mechanism
remains to be studied.
Taken together, the present findings show that HIV-1
gp120  assistance  receptors  of  CXCR4  and  CCR5  are
expressed  on  the  cell  surface  of  HRCEC  (new  defined
uninfected  CXCR4/CCR5-positive  bystander  cells),  and
HIV-1 gp120 is cytotoxic to cultured HRCEC in a dose- and
time-dependent manner. The subsequent analysis of FACS
with annexin V-FITC and PI labeling shows that HRCEC
death induced by different concentrations of HIV-1 gp120
proceeds  through  the  apoptotic  pathway.  The  mechanism
involves the loss of ΔΨm and activation of pro-caspase-9,
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3455indicating  that  the  mitochondrial  pathway  is  probably
associated  with  gp120-induced  apoptosis.  Further
investigation in CXCR4/CCR5 interaction with the HIV-1
envelope and the mitochondria pathway of HRCEC apoptosis
may  ultimately  prove  the  specific  mechanisms  of  HIV-1
related retinopathy.
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